TCG GreenChem facilities in Princeton South, New Jersey (file photo)

In­di­a's TCG launch­es new CD­MO arm state­side to meet the call for 'Amer­i­can-made' pan­dem­ic drugs

Thanks to 57,000 square feet of re­al es­tate in New Jer­sey and Vir­ginia, a new CD­MO arm of In­dia’s TCG Life­sciences now has a US foot­print and will use it to fo­cus on ef­fi­cient and cheap pro­duc­tion of Covid-19 re­lat­ed med­i­cines and oth­er an­tivi­ral drugs.

Called TCG GreenChem, the new man­u­fac­tur­ing sub­sidiary will op­er­ate out of 3,000 square feet of lab space in Vir­ginia Com­mon­wealth Uni­ver­si­ty’s Biotech­nol­o­gy Re­search Park and 54,000 square feet of lab and of­fice space in Prince­ton’s South Cor­po­rate Cen­ter.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.